Showing results (321-330 of 554) with videos related to
Sort By:
Pageof 56
Journal of Acquired Immune Deficiency Syndromes (1999)|July 23, 2008
Fever after a stay in the tropics: clinical spectrum and outcome in HIV-infected travelers and migrantsEmmanuel Bottieau, Eric Florence, Jan Clerinx, et al.The Pediatric Infectious Disease Journal|December 6, 2008
Mortality and associated factors after initiation of pediatric antiretroviral treatment in the Democratic Republic of the CongoSteven F J Callens, Nicole Shabani, Jean Lusiama, et al.AIDS and Behavior|November 9, 2018
Factors Influencing the Risk of Becoming Sexually Active Among HIV Infected Adolescents in Kampala and Kisumu, East AfricaSabrina Bakeera-Kitaka, Tom Smekens, Vicky Jespers, et al.Pathogens (Basel, Switzerland)|August 6, 2020
Ivermectin Treatment Response in Onchocerca Volvulus Infected Persons with Epilepsy: A Three-Country Short Cohort StudyAlfred Dusabimana, Dan Bhwana, Stephen Raimon, et al.Clinical Pharmacology and Therapeutics|January 22, 2024
Population Pharmacokinetics of Pediatric Lopinavir/Ritonavir Oral Pellets in Children Living with HIV in AfricaSuthunya Chupradit, Dalton C Wamalwa, Elizabeth Maleche-Obimbo, et al.AIDS Research and Human Retroviruses|October 27, 2007
Current hemoglobin levels are more predictive of disease progression than hemoglobin measured at baseline in patients receiving antiretroviral treatment for HIV type 1 infectionJustyna D Kowalska, Amanda Mocroft, Anders Blaxhult, et al.Plos Neglected Tropical Diseases|May 26, 2023
Onchocerciasis-associated epilepsy in Maridi, South Sudan: Modelling and exploring the impact of control measures against river blindnessSamit Bhattacharyya, Natalie V S Vinkeles Melchers, Joseph N Siewe Fodjo, et al.Vaccine|May 16, 2002
Long-term follow-up: no effect of therapeutic vaccination with HIV-1 p17/p24:Ty virus-like particles on HIV-1 disease progressionCatharina E A Lindenburg, Ineke Stolte, Miranda W Langendam, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|March 18, 2003
Virologic, immunologic, and clinical response to highly active antiretroviral therapy: the gender issue revisitedAntonia L Moore, Ole Kirk, Anne M Johnson, et al.Antiviral Therapy|May 1, 2012
Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfectionWilliam Worodria, Joris Menten, Marguerite Massinga-Loembe, et al.Pageof 56